ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,198 | +332.5% | 38,961 | +455.5% | 0.63% | +237.4% |
| Q4 2022 | $277 | -99.9% | 7,014 | +10.4% | 0.19% | -72.1% |
| Q3 2022 | $255,000 | -1.9% | 6,354 | -5.1% | 0.67% | +185.1% |
| Q1 2022 | $260,000 | +381.5% | 6,692 | +507.3% | 0.24% | +279.0% |
| Q3 2021 | $54,000 | -81.2% | 1,102 | -80.8% | 0.06% | -80.6% |
| Q4 2020 | $287,000 | +277.6% | 5,736 | +214.5% | 0.32% | +315.6% |
| Q3 2020 | $76,000 | +40.7% | 1,824 | +65.5% | 0.08% | +285.0% |
| Q2 2020 | $54,000 | – | 1,102 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |